Literature DB >> 29880706

MECHANISMS IN ENDOCRINOLOGY: Hypophysitis: diagnosis and treatment.

Mamta N Joshi1, Benjamin C Whitelaw2,3, Paul V Carroll1,3.   

Abstract

Hypophysitis is a rare condition characterised by inflammation of the pituitary gland, usually resulting in hypopituitarism and pituitary enlargement. Pituitary inflammation can occur as a primary hypophysitis (most commonly lymphocytic, granulomatous or xanthomatous disease) or as secondary hypophysitis (as a result of systemic diseases, immunotherapy or alternative sella-based pathologies). Hypophysitis can be classified using anatomical, histopathological and aetiological criteria. Non-invasive diagnosis of hypophysitis remains elusive, and the use of currently available serum anti-pituitary antibodies are limited by low sensitivity and specificity. Newer serum markers such as anti-rabphilin 3A are yet to show consistent diagnostic value and are not yet commercially available. Traditionally considered a very rare condition, the recent recognition of IgG4-related disease and hypophysitis as a consequence of use of immune modulatory therapy has resulted in increased understanding of the pathophysiology of hypophysitis. Modern imaging techniques, histological classification and immune profiling are improving the accuracy of the diagnosis of the patient with hypophysitis. The objective of this review is to bring readers up-to-date with current understanding of conditions presenting as hypophysitis, focussing on recent advances and areas for future development. We describe the presenting features, investigation and diagnostic approach of the patient with likely hypophysitis, including existing conventional techniques and those in the research/development arena. Hypophysitis usually results in acute and persistent pituitary hormone deficiency requiring long-term replacement. Management of hypophysitis includes control of the inflammatory pituitary mass using a variety of treatment strategies including surgery and medical therapy. Glucocorticoids remain the mainstay of medical treatment but other immunosuppressive agents (e.g. azathioprine, rituximab) show benefit in some cases, but there is a need for controlled studies to inform practice.
© 2018 European Society of Endocrinology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29880706     DOI: 10.1530/EJE-17-0009

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  22 in total

Review 1.  IgG4-related hypophysitis.

Authors:  Alireza Amirbaigloo; Fatemeh Esfahanian; Marjan Mouodi; Nasser Rakhshani; Mehdi Zeinalizadeh
Journal:  Endocrine       Date:  2021-04-10       Impact factor: 3.633

2.  Outcomes of Initial Management Strategies in Patients With Autoimmune Lymphocytic Hypophysitis: A Systematic Review and Meta-analysis.

Authors:  Diane Donegan; Zeb Saeed; Danae A Delivanis; Mohammad Hassan Murad; Juergen Honegger; Felix Amereller; Seda Hanife Oguz; Dana Erickson; Irina Bancos
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

Review 3.  Autoimmune diseases of the brain, imaging and clinical review.

Authors:  Ghazal Shadmani; Tyrell J Simkins; Reza Assadsangabi; Michelle Apperson; Lotfi Hacein-Bey; Osama Raslan; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2021-09-07

4.  Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system.

Authors:  Kyla Wright; Hyon Kim; Travis Hill; Matthew Lee; Cordelia Orillac; Nikita Mogar; Donato Pacione; Nidhi Agrawal
Journal:  Pituitary       Date:  2022-05-27       Impact factor: 3.599

Review 5.  Granulomatous hypophysitis causing compression of the internal carotid arteries reversible with azathioprine and rituximab treatment.

Authors:  Pauline Gendreitzig; Jürgen Honegger; Marcus Quinkler
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

6.  MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis.

Authors:  R Kurokawa; Y Ota; W Gonoi; A Hagiwara; M Kurokawa; H Mori; E Maeda; S Amemiya; Y Usui; N Sato; Y Nakata; T Moritani; O Abe
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-06       Impact factor: 3.825

Review 7.  Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation.

Authors:  Sriram Gubbi; Fady Hannah-Shmouni; Joseph G Verbalis; Christian A Koch
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2019-12-12       Impact factor: 4.690

8.  Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database.

Authors:  Julie Garon-Czmil; Nadine Petitpain; Franck Rouby; Marion Sassier; Samy Babai; Mélissa Yéléhé-Okouma; Georges Weryha; Marc Klein; Pierre Gillet
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

9.  Central diabetes insipidus caused by a pituitary stalk germinoma resembling infundibuloneurohypophysitis.

Authors:  Daniela Dias; Helena Vilar; João Passos; Valeriano Leite
Journal:  BMJ Case Rep       Date:  2020-09-09

10.  Autoimmune hypophysitis and viral infection in a pregnant woman: a challengeable case.

Authors:  Kais Benabderrahim
Journal:  Pan Afr Med J       Date:  2020-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.